UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The antiviral drug selected hepatitis B virus rtA181T/sW172 mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

Hepatology (Baltimore, Md.), 2008-07, Vol.48 (1), p.88-98

2008

Volltextzugriff (PDF)

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

Proceedings of the National Academy of Sciences - PNAS, 2015-05, Vol.112 (18), p.5797-5802

2015

Volltextzugriff (PDF)

The new front‐line in hepatitis B/D research: Identification and blocking of a functional receptor

Hepatology (Baltimore, Md.), 2013-07, Vol.58 (1), p.9-12

2013

Volltextzugriff (PDF)

HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism

Molecular cancer research, 2019-07, Vol.17 (7), p.1582-1593

2019

Volltextzugriff (PDF)

The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro

Antimicrobial Agents and Chemotherapy, 2007-07, Vol.51 (7), p.2285-2292

2007

Volltextzugriff (PDF)

Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine

Human vaccines & immunotherapeutics, 2018-06, Vol.14 (6), p.1483-1488

2018

Volltextzugriff (PDF)

Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen

Journal of Virology, 2010-06, Vol.84 (12), p.5860-5867

2010

Volltextzugriff (PDF)

Mechanisms of Hepatitis B Virus Resistance Development

Intervirology, 2014-01, Vol.57 (3-4), p.218-224

2014

Volltextzugriff (PDF)

The role of hepatitis B surface antibodies in HBV infection, disease and clearance

Future virology, 2020-05, Vol.15 (5), p.293-306

2020

Volltextzugriff (PDF)

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

Journal of virology, 2016-11, Vol.90 (22), p.10054-10064

2016

Volltextzugriff (PDF)

Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis

Virology (New York, N.Y.), 2017-01, Vol.501, p.70-78

2017

Volltextzugriff (PDF)

Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A

Journal of hepatology, 2022-01, Vol.76 (1), p.34-45

2022

Volltextzugriff (PDF)

Anti-viral Medication to Prevent HCC Development: Where Are We Now?

Cancer forum, 2009-07, Vol.33 (2), p.111-114

2009

Volltextzugriff (PDF)

Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

Antiviral therapy, 2009, Vol.14 (2), p.139

2009

Volltextzugriff (PDF)

The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling

Cancers, 2020-05, Vol.12 (6), p.1435

2020

Volltextzugriff (PDF)

Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes

Microbial genomics, 2021-01, Vol.7 (1)

2021

Volltextzugriff (PDF)

Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV

Antiviral therapy, 2007-01, Vol.12 Suppl 3 (3_suppl), p.H15-23

2007

Volltextzugriff (PDF)

Article Commentary: Can Antiviral Therapy for Chronic Hepatitis B Enhance the Progression to Hepatocellular Carcinoma?

Antiviral therapy, 2009-02, Vol.14 (2), p.139-142

2009

Volltextzugriff (PDF)

Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV: Clinical management of hepatitis B virus monoinfection and coinfection with HIV

Antiviral therapy, 2007, Vol.12

2007

Volltextzugriff (PDF)

Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits

Antiviral research, 2012-02, Vol.93 (2), p.209-218

2012

Volltextzugriff (PDF)

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro

Oncotarget, 2017-02, Vol.8 (9), p.15704-15715

2017

Volltextzugriff (PDF)

In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co-infection

Journal of medical virology, 2012-08, Vol.84 (8), p.1166-1176

2012

Volltextzugriff (PDF)

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype

Hepatology international, 2013-06, Vol.7 (2), p.443-450

2013

Volltextzugriff (PDF)

HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA

Future Virology, 2012-12, Vol.7 (12), p.1237-1249

2012

Volltextzugriff (PDF)

Replication of Hepatitis B Virus

Zakim & Boyer's Hepatology: A Textbook of Liver Disease, 2012, p.86-96

Sixth Edition, 2012

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(117)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(6)
Genome Announcements
(5)
Antiviral Therapy
(4)
Elife
(4)
Microbiology Resource Announcements
(4)
Cell Reports
(3)
Hepatology
(3)
Plos Pathogens
(3)
The Journal Of Immunology
(3)
Aids Research And Human Retroviruses
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The antiviral drug selected hepatitis B virus rtA181T/sW172 mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

The new front‐line in hepatitis B/D research: Identification and blocking of a functional receptor

HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism

The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro

Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine

Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen

Mechanisms of Hepatitis B Virus Resistance Development

The role of hepatitis B surface antibodies in HBV infection, disease and clearance

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis

Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A

Anti-viral Medication to Prevent HCC Development: Where Are We Now?

Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling

Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes

Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV

Article Commentary: Can Antiviral Therapy for Chronic Hepatitis B Enhance the Progression to Hepatocellular Carcinoma?

Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV: Clinical management of hepatitis B virus monoinfection and coinfection with HIV

Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro

In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co-infection

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype

HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA

Replication of Hepatitis B Virus

Suchergebnisse filtern